355 related articles for article (PubMed ID: 2985320)
1. A comparison of the tumor-seeking agent Tc-99m(V) dimercaptosuccinic acid and the renal imaging agent Tc-99m dimercaptosuccinic acid in humans.
Ohta H; Ishii M; Yoshizumi M; Endo K; Sakahara H; Nakajima T; Yomoda I; Masuda H; Horiuchi K; Hata N
Clin Nucl Med; 1985 Mar; 10(3):167-70. PubMed ID: 2985320
[TBL] [Abstract][Full Text] [Related]
2. Analogy between tumor uptake of technetium(V)-99m dimercaptosuccinic acid (DMSA) and technetium-99m-MDP.
Wulfrank DA; Schelstraete KH; Small F; Fallais CJ
Clin Nucl Med; 1989 Aug; 14(8):588-93. PubMed ID: 2553315
[TBL] [Abstract][Full Text] [Related]
3. Imaging of head and neck tumors with technetium(V)-99m DMSA. A new tumor-seeking agent.
Ohta H; Endo K; Fujita T; Nakashima T; Sakahara H; Torizuka K; Shimizu Y; Ishii Y; Makimoto K; Hata N
Clin Nucl Med; 1985 Dec; 10(12):855-60. PubMed ID: 3000682
[TBL] [Abstract][Full Text] [Related]
4. False-positive technetium-99m DMSA renal imaging in two cases of malrotated kidney.
Ueno K; Rikimaru S; Miyagi T; Mohri S
Clin Nucl Med; 1985 Jul; 10(7):504-6. PubMed ID: 2992862
[TBL] [Abstract][Full Text] [Related]
5. The detection of nasopharynx carcinoma in technetium-99m (V) dimercaptosuccinic acid SPECT imaging.
Kao CH; Wang SJ; Wey SP; Shen LH; Ting G; Yeh SH
Clin Nucl Med; 1993 Apr; 18(4):321-3. PubMed ID: 8386992
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of tumour imaging using 99Tc(V)m dimercaptosuccinic acid, a new tumour-seeking agent.
Ohta H; Endo K; Fujita T; Konishi J; Torizuka K; Horiuchi K; Yokoyama A
Nucl Med Commun; 1988 Feb; 9(2):105-16. PubMed ID: 2838772
[TBL] [Abstract][Full Text] [Related]
7. Images of liposarcoma using technetium-99m bleomycin and technetium (V)-99m DMSA.
Ohta H; Shane FI; Endo K; Torizuka K; Horiuchi K; Yokoyama A; Ishii M
Clin Nucl Med; 1986 Dec; 11(12):842-4. PubMed ID: 2434276
[TBL] [Abstract][Full Text] [Related]
8. 99mTechnetium(V) dimercaptosuccinic acid (99mTc(v) DMSA) as a tumour seeking agent in nasopharyngeal carcinoma.
Aw SE; Sundram FX; Goh AS
Ann Acad Med Singap; 1986 Oct; 15(4):498-501. PubMed ID: 3032068
[TBL] [Abstract][Full Text] [Related]
9. Pentavalent technetium-99m (V)-DMSA uptake in a pheochromocytoma in a patient with Sipple's syndrome.
Adams BK; Fataar A; Byrne MJ; Levitt NS; Matley PJ
J Nucl Med; 1990 Jan; 31(1):106-8. PubMed ID: 1967305
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m DMSA abnormal uptake by metastatic lesion of a renal cell carcinoma.
Kosuda S; Hirono Y; Yoshinaga H; Saito K; Tamura K; Kubo A; Hashimoto S
Clin Nucl Med; 1986 Jun; 11(6):432-3. PubMed ID: 3013485
[No Abstract] [Full Text] [Related]
11. Myocardial infarct imaging in patients with technetium-99m 2,3-dimercaptosuccinic acid. Superiority of technetium-99m pyrophosphate.
Lyons KP; Milne N; Karlsberg RP; Olson HG; Kuperus J
Clin Nucl Med; 1987 Jul; 12(7):514-8. PubMed ID: 3038447
[TBL] [Abstract][Full Text] [Related]
12. Evidence that 99mTc-(V)-DMSA uptake is mediated by NaPi cotransporter type III in tumour cell lines.
Denoyer D; Perek N; Le Jeune N; Frere D; Dubois F
Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):77-84. PubMed ID: 14557898
[TBL] [Abstract][Full Text] [Related]
13. Differential renal function using technetium-99m dimercaptosuccinic acid (DMSA): in vitro correlation.
Daly MJ; Jones W; Rudd TG; Tremann J
J Nucl Med; 1979 Jan; 20(1):63-6. PubMed ID: 219166
[TBL] [Abstract][Full Text] [Related]
14. [Scintigraphy with technetium dimercaptosuccinic acid (99 m TC DMSA). Contribution to the functional assessment of individual kidneys (author's transl)].
Abbou CC; Moretti JL; Chopin D; Sanabria E; Msallag M; Nebout T; Auvert J
Nouv Presse Med; 1981 Apr; 10(18):1475-8. PubMed ID: 6265862
[TBL] [Abstract][Full Text] [Related]
15. Oxygen bubbling can improve the labelling of pentavalent technetium-99m dimercaptosuccinic acid.
Kobayashi H; Suzuki KH; Sakahara H; Yao ZS; Yokoyama A; Konishi J
Eur J Nucl Med; 1995 Jun; 22(6):559-62. PubMed ID: 7556304
[TBL] [Abstract][Full Text] [Related]
16. The visualization of pulmonary tuberculosis with Tc-99m (V) DMSA and Tc-99m citrate in comparison to Ga-67 citrate.
Gulaldi NC; Bayhan H; Ercan MT; Kibar M; Oztürk B; Oğretensoy M; Bekdik CF
Clin Nucl Med; 1995 Nov; 20(11):1012-4. PubMed ID: 8565355
[TBL] [Abstract][Full Text] [Related]
17. Sipple's syndrome with liver tumors examined by iodine-131 MIBG and technetium-99m(V)-DMSA.
Ohta H; Endo K; Fujita T; Koizumi M; Konishi J; Maki A; Mori K; Ozawa K; Inoue G; Nakano Y
J Nucl Med; 1988 Jun; 29(6):1130-5. PubMed ID: 2897436
[TBL] [Abstract][Full Text] [Related]
18. Technetium-99m(V)-DMSA in the imaging of medullary thyroid carcinoma.
J Nucl Med; 1987 Feb; 28(2):252-3. PubMed ID: 3027281
[No Abstract] [Full Text] [Related]
19. Diagnostic value of Tc-99m (V) DMSA for chondrogenic tumors with positive Tc-99m HMDP uptake on bone scintigraphy.
Kobayashi H; Kotoura Y; Hosono M; Sakahara H; Hosono M; Yao ZS; Tsuboyama T; Yamamuro T; Endo K; Konishi J
Clin Nucl Med; 1995 Apr; 20(4):361-4. PubMed ID: 7788996
[TBL] [Abstract][Full Text] [Related]
20. [Quantification of separate renal function using Tc 99m DTPA and Tc 99m DMSA. Correlations between individual isotopic data and creatinine clearance].
Chevet D; Moisan A; Le Pogamp P; Le Cloirec J; Wehbe B; Herry JY
Nephrologie; 1984; 5(1):21-5. PubMed ID: 6328339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
